ロード中...
MEK1 is required for the development of NRAS-driven leukemia
The dual-specificity kinases MEK1 and MEK2 act downstream of RAS/RAF to induce ERK activation, which is generally considered protumorigenic. Activating MEK mutations have not been discovered in leukemia, in which pathway activation is caused by mutations in upstream components such as RAS or Flt3. T...
保存先:
| 出版年: | Oncotarget |
|---|---|
| 主要な著者: | , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Impact Journals LLC
2016
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5348309/ https://ncbi.nlm.nih.gov/pubmed/27741509 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.12555 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|